Adding a Kinase to Pembrolizumab May Increase CLL Treatment Efficacy

Retrieved on: 2024-07-16 21:03:03

Tags for this article:

Click the tags to see associated articles and topics

Adding a Kinase to Pembrolizumab May Increase CLL Treatment Efficacy. View article details on hiswai:

Excerpt

Adding BCR kinase inhibitor ibrutinib or idelalisib to monoclonal antibody pembrolizumab increases treatment efficacy in CLL with Richter ...

Article found on: www.physiciansweekly.com